The influence of adaptogens on ultraweak biophoton emission: a pilot-experiment.
In the present study, the effect of plant adaptogens (Rhodiola rosea and ADAPT-232) on human photon emission has been determined. In a randomized double blind placebo-controlled study, 30 subjects were randomly assigned to three groups: one group (n = 10) taking placebo pills, one group (n = 10) taking Rhodiola rosea (SHR-5) pills and one group (n = 10) taking ADAPT-232 supplements (the latter being a fixed combination of the following three adaptogens: Eleutherococcus senticosus, Rhodiola rosea and Schisandra chinensis). All subjects underwent measurements to determine ultra-weak photon emission (UPE) of the dorsal side of their hands using a photon-counting device, both before and after a week of taking the supplements. In addition, the experienced levels of stress and fatigue (tiredness) were evaluated. After 1 week of supplementation, the Rhodiola group showed a significant decrease (p = 0.027) in photon emission in comparison with the placebo group. Furthermore, after supplementation, a significant decrease (p = 0.049) concerning the experienced level of fatigue in the Rhodiola group was observed compared with the placebo group. No significant changes were observed between the ADAPT-232 and the placebo group.
Schutgens
F W G
FW
University College Utrecht, The Netherlands.
Neogi
P
P
van Wijk
E P A
EP
van Wijk
R
R
Wikman
G
G
Wiegant
F A C
FA
D000328:Adult; D004311:Double-Blind Method; D005221:Fatigue / Q000188:drug therapy; D005260:Female; D006225:Hand / Q000502:physiology; D006801:Humans; D008297:Male; D017785:Photons; D008517:Phytotherapy; D010865:Pilot Projects; D010936:Plant Extracts / Q000008:administration & dosage*; D029771:Rhodiola / Q000737:chemistry*; D013315:Stress, Psychological / Q000188:drug therapy; D055815:Young Adult
D010936:Plant Extracts